✦ LIBER ✦

Long-term clinical effect of nilvadipine in patients with chronic heart failure: A double-blind placebo-controlled study

✍ Scribed by Masatsugu Hori; Hideyuki Sato; Michiko Karita; Kazuhisa Kodama; Noritake Hoki; Tohru Hayashi; Masashi Naka; Shinsuke Nanto; Yoshio Yamada; Takenobu Kamada

Publisher: Springer
Year: 1994
Tongue: English
Weight: 507 KB
Volume: 9
Category: Article
ISSN: 0910-8327
DOI: 10.1007/bf01745105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled, randomized, double

A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure

✍ Shigetake Sasayama 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 629 KB

Peripheral hemodynamic effects of ibopam

Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study

✍ C. Longhini; L. Ansani; G. F. Musacci; S. Aggio; E. Baracca; T. Toselli; P. Ghir 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 282 KB

Effect of flosequinan on exercise capaci

Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: A double-blind placebo-controlled study

✍ Masatsugu Hori; Hideyuki Sato; Hitoshi Ozaki; Michitoshi Inoue; Masashi Naka; Ma 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 813 KB

Digoxin and xamoterol in patients with m

Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study

✍ E. Vigholt Sorensen; Bent Sterndorff; M. Friis Andersen; Ole Faergeman 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 515 KB

Double-blind placebo controlled clinical

Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency

✍ I. Bakran; B. Vrhovac; B. Štangl; Đ. Tabori; A. Ivičevic; V. Todič; F. Kandare 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 518 KB

The efficacy and safety of almitrine bismesylate, a new respiratory stimulant, in patients with the hypoxaemic form of chronic respiratory insufficiency caused by chronic bronchitis and emphysema has been assessed. The multicentre trial of 12 weeks duration was double-blind and placebo controlled, w

A double-blind placebo-controlled study

A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis

✍ Simon Carette; Andrei Calin; Jim P. McCafferty; Bruce A. Wallin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 759 KB